Avacta Group PLC: Will AVCT Stock Retest the £125 Mark?

• Avacta Group completed the 5th dose escalation in the Chemotherapy drug trial.
• Avacta Group acquires Belgium’s Coris BioConcept for £7.4 Million.
• AVCT stock price is trading at £106.6 with a return of -0.93% during the intraday session.

Avacta Group PLC is a Leeds-based life sciences company focused on improving people’s health and well-being through targeted oncology, drugs, and powerful diagnostics and therapeutics.

In early 2023, Avacta’s stock price achieved an annual high at £188 on February 8. From there, the price has been in a downtrend for about six months, forming lower highs and lower lows. This bearish momentum resulted in a downfall of roughly 53% from the annual high to the present.

The current sentiment of AVCT stock price has been in bullish momentum since July 28, when the stock price gained an upward momentum after an expect pullback. The weekly and monthly returns also reflect the same, with a return of 5.29% and 3.40%, respectively.

Avacta Group PLC Acquires Coris BioConcept.

In early June 2023, Avacta Group completed the purchase of Belgium’s diagnostic kit manufacturer Coris BioConcept for £7.5 Million, which is essential for Avatca to establish a full-spectrum in-vitro diagnostics business, including centralized and decentralized testing solutions and pathology laboratory diagnostics.

After Coris BioConcept was acquired, AVCT stock price increased by more than 15% in price action. 

A recent Surge of around 20% in Avacta Stock was witnessed after Avacta completed the fifth dose escalation in its phase 1 trial for the Chemotherapy drug AVA6000.

The stock price is recently hovering near the early June support level of £106. If the upward momentum remains, the bulls can push the price above the £125 resistance level.  

On the contrary, if the bears can pull the price below the previous low of £100.6, then AVCT stock price might melt down toward the annual low of £88, which will cause a downfall of roughly 18%.

Will The AVCT Stock Price Retest The Previous High?

Also, AVCT stock price is currently trading above the 20 and 50-day EMAs, indicating strength and a rise in the participation of buyers in the market. However, rejection from the 100 and 200-day EMA is possible.

The RSI trades at 56.65, and it denotes the bullish momentum in the market during the intraday session. However, the chaikin money flow (CMF) score has traded below the 0 mark since 24 February 2023. CMF scored -0.13, indicating weakness in the market.

The current market capitalization of AVCT stock price is £298.86 Million, with an average volume of  1.30 Million shares.

Conclusion 

In Conclusion, with the recent developments in Avacta Group PLC, there is hope for growth which creates a perfect opportunity for buyers to buy cheap shares of the company.

Technical Levels

• Major resistance: £188.0 and £148.8
• Major support: £88.0 and £98.3

Disclaimer

The views and opinions stated by the author, or any people named in this article, are for informational purposes only. They do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.